Lilly - November 2023 - case study 2

Start date:

Developing a pathway for the early and accurate diagnosis of Alzheimer’s Disease (AD) including biomarker assessment via cerebrospinal fluid (CSF)

NHS Organisation(s) Oxford Health NHS Foundation Trust, Greater Manchester Mental Health NHS Foundation Trust, University Hospitals Sussex NHS Trust, Sheffield Teaching Hospitals NHS Foundation Trust
Project focus Neurology
Project Type Joint Working
Company Lilly

The project has won two HSJ awards, Best Pharmaceutical Partnership with NHS 2025 and Best Partnership of the Year 2025. 

 

Link for further information
Open the Lilly website

Last reviewed date: 30 April 2026

Next review date: 30 April 2029